loxoprofen has been researched along with Breast Cancer in 1 studies
loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Y | 1 |
| Suo, H | 1 |
| Yang, X | 1 |
| Zhao, X | 1 |
| Zhou, X | 1 |
1 other study available for loxoprofen and Breast Cancer
| Article | Year |
|---|---|
Eu(III) complex based on nonsteroidal anti-inflammatory drugs loxoprofen as the ligand: A novel low-toxic luminescent material for cell imaging.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Proliferation | 2020 |